The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Bone metastases: an overview
Open accessAbstract
Bone is a frequent site of metastases and typically indicates a short-term prognosis in cancer patients. Once cancer has spread to the bones it can rarely be cured, but often it can still be treated to slow its growth. The majority of skeletal metastases are due to breast and prostate cancer. Bone metastasis is actually much more common than primary bone cancers, especially in adults. The diagnosis is based on signs, symptoms and imaging. New classes of drugs and new interventions are given a better quality of life to these patients and improved the expectancy of life. It is necessary a multidisciplinary approach to treat patients with bone metastasis. In this paper we review the types, clinical approach and treatment of bone metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408 · cited 1×
“Radium- -223 significantly prolonged overall survival in patients who had castration- -resistant prostate cancer and bone metastases, with a 30%reduction in the risk of death [55].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Multistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,243
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Côté, D., Means, T. K., Luster, A. D., Scadden, D. T., & Lin, C. P. (2005) · Nature · doi:10.1038/nature03703 · Cited by 878
Regulation of cancer cell migration and bone metastasis by RANKL.
Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., et al. (2006) · Nature · doi:10.1038/nature04524 · Cited by 796
Tong, D., Gillick, L., & Hendrickson, F. R. (1982) · Cancer · doi:10.1002/1097-0142(19820901)50:5<893::aid-cncr2820500515>3.0.co;2-y · Cited by 790
Denosumab and bisphosphonates: Different mechanisms of action and effects
Baron, R., Ferrari, S., & Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2010.11.020 · Cited by 715
Bone health in cancer patients: ESMO Clinical Practice Guidelines
Coleman, R., Body, J. J., Aapro, M., Hadji, P., & Herrstedt, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu103 · Cited by 564
Bone metastases: pathophysiology and management policy.
Nielsen, O. S., Munro, A. J., & Tannock, I. F. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.509 · Cited by 486
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
SHREVE, P. D., Grossman, H. B., Gross, M. D., & Wahl, R. L. (1996) · Radiology · doi:10.1148/radiology.199.3.8638000 · Cited by 395
Staging Non-Small Cell Lung Cancer with Whole-Body PET
Marom, E. M., McAdams, H. P., Erasmus, J. J., Goodman, P. C., Culhane, D. K., Coleman, R. E., Herndon, J. E., & Patz, E. F. (1999) · Radiology · doi:10.1148/radiology.212.3.r99se21803 · Cited by 384
Schirrmeister, H., Guhlmann, A., Elsner, K., Kotzerke, J., Glatting, G., Rentschler, M., Neumaier, B., Träger, H., Nüssle, K., & Reske, S. N. (1999) · PubMed · Cited by 329
Percutaneous image‐guided cryoablation of painful metastases involving bone: Multicenter trial
Callstrom, M. R., Dupuy, D. E., Solomon, S. B., Beres, R. A., Littrup, P. J., Davis, K. W., Paz‐Fumagalli, R., Hoffman, C., Atwell, T. D., Charboneau, J. W., et al. (2013) · Cancer · doi:10.1002/cncr.27793 · Cited by 298
Clinical course and prognostic factors following bone recurrence from breast cancer
Coleman, R., Smith, P., & Rubens, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.52 · Cited by 293
Rogers, M. J., Watts, D. J., & Russell, R. G. G. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z · Cited by 285
Management of bone metastases in cancer: A review
Selvaggi, G., & Scagliotti, G. V. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.03.011 · Cited by 266
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Prostate Carcinoma Skeletal Metastases: Cross-talk between Tumor and Bone
Keller, E. T., Zhang, J., Cooper, C. R., Smith, P. C., McCauley, L. K., Pienta, K. J., & Taichman, R. S. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015599831232 · Cited by 198
Critical steps in hematogenous metastasis: an overview.
Chambers, A. F., Naumov, G. N., Varghese, H. J., Nadkarni, K. V., MacDonald, I. C., & Groom, A. C. (2001) · PubMed · Cited by 191
Hadji, P., Aapro, M. S., Body, J. J., Bundred, N. J., Brufsky, A., Coleman, R. E., Gnant, M., Guise, T., & Lipton, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr017 · Cited by 191
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
Chlebowski, R. T., Chen, Z., Cauley, J. A., Anderson, G., Rodabough, R. J., McTiernan, A., Lane, D. S., Manson, J. E., Snetselaar, L., Yasmeen, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2095 · Cited by 187
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
Taube, T., Elomaa, I., Blomqvist, C., Beneton, M. N. C., & Kanis, J. A. (1994) · Bone · doi:10.1016/8756-3282(94)90703-x · Cited by 171
Transcription factors in bone: developmental and pathological aspects
Yang, X., & Karsenty, G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02340-7 · Cited by 166
Vinholes, J. J. F., Prakash Purohit, O., Abbey, M. E., Eastell, R., & Coleman, R. E. (1997) · Annals of Oncology · doi:10.1023/a:1008238422151 · Cited by 163
Thacker, P. G., Callstrom, M. R., Curry, T. B., Mandrekar, J. N., Atwell, T. D., Goetz, M. P., & Rubin, J. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.6029 · Cited by 155
Bisphosphonates in multiple myeloma
Djulbegović, B., Wheatley, K., Ross, H. F., Clark, O. A. C., Bos, G. M. J., Goldschmidt, H., Cremer, F. W., Alsina, M., & Glasmacher, A. G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003188 · Cited by 141
Adhesion and homing of blood-borne cells in bone marrow microvessels
Mazo, I. B., & von Andrian, U. H. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.1.25 · Cited by 127
Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review
Migliorati, C. A., Epstein, J. B., Abt, E., & Berenson, J. R. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.195 · Cited by 125
Guenther, A., Gordon, S., Tiemann, M., Burger, R., Bakker, F., Green, J. R., Baum, W., Roelofs, A. J., Rogers, M. J., & Gramatzki, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24758 · Cited by 125
Vinholes, J., Coleman, R. E., & Eastell, R. (1996) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(96)90021-3 · Cited by 117
Russell, H. V., Hicks, J. M., Okcu, M. F., & Nuchtern, J. G. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.06.019 · Cited by 111
Anastasilakis, A. D., Toulis, K. A., Goulis, D. G., Pοlyzos, S. A., Delaroudis, S., Giomisi, A., & Terpos, E. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1224109 · Cited by 101
Use of Bisphosphonates and Reduced Risk of Colorectal Cancer
Rennert, G., Pinchev, M., Rennert, H. S., & Gruber, S. B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7485 · Cited by 97
Use of bisphosphonates in cancer patients
Body, J., Coleman, R. E., & Piccart, M. J. (1996) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(96)90020-1 · Cited by 89
Wellington, K., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363040-00009 · Cited by 88
Dedes, P. G., Gialeli, C., Tsonis, A., Kanakis, I., Theocharis, A. D., Kletsas, D., Tzanakakis, G. N., & Karamanos, N. K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.013 · Cited by 81
Lee, R. J., Saylor, P. J., Michaelson, M. D., Rothenberg, S. M., Smas, M. E., Miyamoto, D. T., Gurski, C., Xie, W., Maheswaran, S., Haber, D. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0319 · Cited by 73
HOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?
Robson, M., & Dawson, N. A. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70364-6 · Cited by 71
Rogers, M. J., Xiong, X., Ji, X., Mönkkönen, J., Russell, R. G. G., Williamson, M. P., Ebetino, F. H., & Watts, D. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012157212793 · Cited by 68
Kohno, N., Kitazawa, S., Fukase, M., Sakoda, Y., Kanbara, Y., Furuya, Y., Ohashi, O., ISHIKAWA, Y., & Saitoh, Y. (1994) · Surgery Today · doi:10.1007/bf02032890 · Cited by 59
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion
Steger, G. G., & Bartsch, R. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011412656 · Cited by 57
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
Raje, N. S., & Yee (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s14566 · Cited by 49
Novel therapeutic approaches to cancer patients with bone metastasis
Maisano, R., Pergolizzi, S., & Cascinu, S. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00092-0 · Cited by 48
The Role of Stereotactic Radiosurgery in Metastasis to the Spine
Sohn, S., & Chung, C. K. (2012) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2012.51.1.1 · Cited by 43
Cited by
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Antonarakis, E. S., Piulats, J. M., Gross-Goupil, M., Goh, J., Ojamaa, K., Hoimes, C. J., Vaishampayan, U., Berger, R., Sezer, A., Alanko, T., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01638 · Cited by 736
Extracellular Matrix Alterations in Metastatic Processes
Paolillo, M., & Schinelli, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194947 · Cited by 377
Breast cancer detection using deep learning: Datasets, methods, and challenges ahead
din, N. M. U., Dar, R. A., Rasool, M., & Assad, A. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106073 · Cited by 363
Nicolatou-Galitis, O., Schiødt, M., Mendes, R. A., Ripamonti, C., Hope, S., Drudge-Coates, L., Niepel, D., & Van den Wyngaert, T. (2019) · Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.09.008 · Cited by 361
Metadata
- Authors
- Macedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F.
- Venue
- Oncology Reviews
- Publisher
- Frontiers Media SA
- Published
- 2017-05-09
- Volume
- 11
- Issue
- 1
- Pages
- 321-321
- ISSN
- 1970-5557 (ISSN-L)
- 1970-5565
- OpenAlex
- W2612478849
- Cited by
- 775
- References
- 53
- FWCI
- 24.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.